Evidence mapPaperPMID 37111688Full record

ArticlePharmaceutics2023

Miriam Cabello-Olmo, María Oneca, Raquel Urtasun, María J Pajares, Saioa Goñi, José I Riezu-Boj, Fermín I Milagro, Josune Ayo, Ignacio J Encio, Miguel Barajas and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Postbiotic pA1cInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Heat-InactivatedInternational journal of molecular sciences · 2025
    Article
  6. Efficacy ofFrontiers in immunology · 2025
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Miriam Cabello-OlmoBiochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain.ORCID 0000-0001-5024-7675
María OnecaGenbioma Aplicaciones S.L. Polígono Industrial Noain-Esquíroz, Calle S, Nave 4, 31191 Esquíroz, Spain.ORCID 0000-0003-0949-4804
Raquel UrtasunBiochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain.ORCID 0000-0003-2332-5361
María J PajaresBiochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain.ORCID 0000-0002-9427-7937
Saioa GoñiBiochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain.ORCID 0000-0002-2368-7373
José I Riezu-BojIDISNA Navarra's Health Research Institute, 31008 Pamplona, Spain.ORCID 0000-0002-1885-8457
Fermín I MilagroIDISNA Navarra's Health Research Institute, 31008 Pamplona, Spain.ORCID 0000-0002-3228-9916
Josune AyoGenbioma Aplicaciones S.L. Polígono Industrial Noain-Esquíroz, Calle S, Nave 4, 31191 Esquíroz, Spain.
Ignacio J EncioBiochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain.ORCID 0000-0003-1732-1989
Miguel BarajasBiochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain.ORCID 0000-0003-4004-1432
Miriam ArañaBiochemistry Area, Department of Health Science, Public University of Navarre, 31008 Pamplona, Spain.ORCID 0000-0002-5363-896X
Universidad Publica de Navarra · ESInstituto de Salud Carlos III · ESNavarre Institute of Health Research · ES

Funding

Government of Navarre (Ayudas para la realización de proyectos de I+D 2020) 0011-1365-2020-000086
6 · The paper itself

Abstract

Type 2 diabetes (T2D) is a complex metabolic disease, which involves maintained hyperglycemia, mainly due to the development of an insulin resistance process. Metformin administration is the most prescribed treatment for diabetic patients. In a previously published study, we demonstrated that

Indexed as

diabetesglycaemiahigh-fat dietintestinal microbiotametforminPediococcus acidilacticiprobiotic

Identifiers

PMID37111688
PMCPMC10143274
OpenAlexW4363647807

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.